SCHEMBL3376342

SCHEMBL3376342

O=C1c2cccc(O)c2C(=O)N1c1ccc(OC(F)(F)F)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR9 P51686 1/20 0.47
ANPEP P15144 2/20 0.47
DPP4 P27487 2/20 0.47
KDM4E B2RXH2 1/20 0.43
HPGD P15428 1/20 0.43
ADORA2A P29274 1/20 0.43
HSPA1A P0DMV8 1/20 0.42
PABPC1 P11940 1/20 0.42
BRD4 O60885 1/20 0.42
TOP2A P11388 1/20 0.41
TOP2B Q02880 1/20 0.41
TYMS P04818 1/20 0.41
KMT2A Q03164 3/20 0.40
POLB P06746 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
AHR P35869 1/20 0.40
MEN1 O00255 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
MAPT P10636 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4432198 0.85 HSPA1A (0.61) CCR9DPP4KDM4EHPGDADORA2A
SCHEMBL4419914 0.84 CCR9 (0.47) CCR9KDM4EHPGDADORA2AHSPA1A
SCHEMBL29168850 0.82 KMT2A (0.57) KDM4EKMT2APOLBL3MBTL1MEN1
SCHEMBL30758589 0.82 KMT2A (0.57) KDM4EKMT2APOLBL3MBTL1MEN1
SCHEMBL28483525 0.82 CCR9 (0.45) CCR9KDM4EHPGDADORA2AHSPA1A
SCHEMBL3373539 0.82 ANPEP (0.54) CCR9ANPEPDPP4ADORA2AHSPA1A
SCHEMBL3373257 0.80 LMNA (0.47) ANPEPDPP4TYMS
SCHEMBL3375918 0.80 CCR9 (0.48) CCR9KDM4EHPGDADORA2AHSPA1A
SCHEMBL4424847 0.80 KDM4E (0.55) CCR9KDM4EADORA2AHSPA1APABPC1
SCHEMBL3371679 0.80 ANPEP (0.48) ANPEPDPP4ADORA2AHSPA1APABPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1517886-B1 NOVEL PHTHALAMIDE DERIVATIVES BAYER CROPSCIENCE AG (DE) 2010-11-10 EP disclosed
US-7132455-B2 Phthalamide derivatives BAYER CROPSCIENCE AG (DE) 2006-11-07 US disclosed
US-20060035967-A1 Novel phthalamide derivatives BAYER INTELLECTUAL PROPERTY GMBH (DE) 2006-02-16 US disclosed
EP-1517886-A1 NOVEL PHTHALAMIDE DERIVATIVES Bayer CropScience AG (DE) 2005-03-30 EP disclosed
WO-2004000796-A1 NOVEL PHTHALAMIDE DERIVATIVES BAYER CROPSCIENCE AG (DE) 2003-12-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060035967-A1 Novel phthalamide derivatives HDAC1, HDAC2, CRY1 CCR9 4535/4885ANPEP 3368/4885DPP4 1795/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.